CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice. - Wikidata - wikimedia - TriplyDB

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

http://www.wikidata.org/entity/Q37463344

about

Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic mice Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female mice

P2860

Q27344569-AC73D2BB-D0AD-4CC1-AC6C-90E4B33068D2 Q41826140-F0842C1A-08C6-474B-96DB-2779BB486A40

P2860

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

http://www.wikidata.org/entity/Q37463344

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

@en

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

@nl

type

label

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

@en

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

@nl

prefLabel

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

@en

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

@nl

P1433

Q37463344-337E213B-8E18-4344-A111-5120414D067C

P1476

Q37463344-BC8AD2D0-DC49-4450-8839-C5ED2096BA7F

P2093

Q37463344-396C1112-17EA-4C5F-BE98-29302F310457

Q37463344-5D801DCA-5419-4ED3-A411-E073BC7E8368

Q37463344-6B1628F1-3A60-4DE4-B13D-B3237B6D5CD5

Q37463344-9FAC7E76-8BB2-477E-8617-1173CB5C7EFE

Q37463344-E534AD07-D94A-4F2E-AC52-1A3D37357F71

Q37463344-F042D917-8F1E-4167-BE6F-4E204922C778

P2860

Q37463344-011308CC-4D9E-4053-944C-DBF32CBCD274

Q37463344-02852913-C82B-4A10-8732-C4D439C18318

Q37463344-0DF48C1E-56CD-4BB9-8F72-5329E166E4A5

Q37463344-162D7773-DF14-44F9-9067-50BA2CAF63BA

Q37463344-37161659-1DBD-4535-9931-2D6269F94E7D

Q37463344-45B11C9D-DA81-4C89-B8B9-50B1B93AE51C

Q37463344-46A89CCF-049E-447B-93EB-BB0DE7F819C4

Q37463344-4B6E9471-1B7C-4391-9194-142E19FF5B3D

Q37463344-4B86FD43-356E-44EF-9E29-98F291098694

Q37463344-52C82FDD-3C0C-4C82-A477-6C751BBE03E1

P304

Q37463344-68F0CF09-70BE-4B69-9FB5-9373B1BFBB53

P31

Q37463344-C40BA261-2CED-4F3A-B529-4BBAB9A9AE29

P356

Q37463344-12FB3FA9-5B24-4A68-9FD3-A64FD2FE62CC

P433

Q37463344-B79AD715-439C-4BE9-8F97-EB0974ED100E

P478

Q37463344-4B661DF4-4997-442B-AFEF-90503F1EA45A

P50

Q37463344-10EC2687-72E8-434F-A1BE-C2F3B3AF5761

Q37463344-D7DFE0A7-499A-4825-9D2D-C14310F25F57

P577

Q37463344-2B4AD2F6-0D62-4B9C-977E-96E9B7966E37

P698

Q37463344-8E8CC8C1-5DBC-439B-BAFE-935B6F4D8BF0

P921

Q37463344-9AB60602-428D-4BE7-A39F-E2C94A807085

P932

Q37463344-E7ADFA2E-AF8D-45B9-B14C-F6C95A149CE6

P356

JLR.M900186-JLR200

P1433

Journal of Lipid Research

P1476

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

@en

P2093

Anita M van den Hoek

http://www.w3.org/2001/XMLSchema#string

Hans M G Princen

http://www.w3.org/2001/XMLSchema#string

Patrick C N Rensen

http://www.w3.org/2001/XMLSchema#string

Peter J Voshol

http://www.w3.org/2001/XMLSchema#string

Silvia Bijland

http://www.w3.org/2001/XMLSchema#string

Sjoerd A A van den Berg

http://www.w3.org/2001/XMLSchema#string

P2860

Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

JTT-705: is there still future for a CETP inhibitor after torcetrapib?

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

Effects of torcetrapib in patients at high risk for coronary events

High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.

ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.

Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences.

P304

97-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M900186-JLR200

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Ko Willems van Dijk

Louis M Havekes

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19564641

http://www.w3.org/2001/XMLSchema#string

P921

P932

2789790

http://www.w3.org/2001/XMLSchema#string